HOXA2 exerts anti-renal fibrosis effects through reducing endoplasmic reticulum stress via the upregulation of SIRT1

Wait 5 sec.

HOXA2 exerts anti-renal fibrosis effects through reducing endoplasmic reticulum stress via the upregulation of SIRT1Download PDF Download PDF ArticleOpen accessPublished: 30 December 2025Xin Li1 na1,Tian-Kui Ma2 na1,Xiao-Xu Deng3 na1,Sang Hai1,Fang Ma1,Yun Zou1,Qi Yang1,Hui Lyu  ORCID: orcid.org/0000-0003-2864-55914,Yu-Xi Li5 &…Hong Ding  ORCID: orcid.org/0009-0006-9968-778X1 Communications Biology , Article number:  (2025) Cite this article We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.SubjectsChronic kidney diseaseDNA methylationAbstractRelieving renal fibrosis are promising therapeutic strategies for chronic kidney disease (CKD). Here we showed that decreased homeobox A2 (HOXA2) expression with excessive ER stress activation were observed in the renal tissues of UUO mice established on male C57BL/6 mice and TGF-β1-induced human proximal tubular epithelial cells (HK-2 cells). After transfected HOXA2 overexpression plasmids into HK-2 cells and administered adeno-associated virus (AAV) containing HOXA2 to UUO mice, the expression of ER stress markers such as ATF6, GRP78 and CHOP decreased, renal dysfunction and fibrosis were significantly attenuated. Mechanistically, HOXA2 binds to the SIRT1 promoter, enhancing SIRT1 transcription and deacetylase activity, which led to ATF6 deacetylation and downregulation. The protective effect of HOXA2 was confirmed against the ER stress agonist thapsigargin. Moreover, DNMT1-mediated promoter methylation was identified as a potential mechanism for HOXA2 suppression in fibrosis. Targeting HOXA2 maybe an innovative therapeutic strategy for fibrosis treatment in CKD.Data availabilityThe source data and the statistical data can be found in Supplementary Data 1 and Supplementary Materials and DNA-sequencing results can be found in NCBI database (SRA: PRJNA1377853). The data that support the findings of this study are available on request from the corresponding author.ReferencesFountoulakis, N., Miyamoto, Y., Pavkov, M. E., Karalliedde, J. & Maltese, G. Pathophysiology of vascular ageing and the effect of novel cardio-renal protective medications in preventing progression of chronic kidney disease in people living with diabetes. Diabet. Med 42, e15464 (2025).Google Scholar Bhayana, S., Schytz, P. A., Bisgaard Olesen, E. T., Soh, K. & Das, V. Single-Cell Advances in Investigating and Understanding Chronic Kidney Disease and Diabetic Kidney Disease. Am. J. Pathol. 195, 55–68 (2025).Google Scholar Maeda, S. et al. MondoA and AKI and AKI-to-CKD Transition. J. Am. Soc. Nephrol. 35, 1164–1182 (2024).Google Scholar Huang, R., Fu, P. & Ma, L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct. Target Ther. 8, 129 (2023).Google Scholar Wang, Y. et al. Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway. PLoS One 19, e0299389 (2024).Google Scholar Hadpech, S. & Thongboonkerd, V. Epithelial-mesenchymal plasticity in kidney fibrosis. Genesis 62, e23529 (2024).Google Scholar Jiang, W. et al. Eucommiae cortex extract alleviates renal fibrosis in CKD mice induced by adenine through the TGF-β1/Smad signaling pathway. J. Nat. Med 79, 170–179 (2025).Google Scholar Cohen, C. et al. WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease. Nat. Commun. 15, 743 (2024).Google Scholar Wu, Y. et al. Renalase Prevents Renal Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Down-Regulating GSK-3β/Snail Signaling. Int J. Med Sci. 20, 669–681 (2023).Google Scholar Andrade-Silva, M. et al. The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fibrosis. Kidney Int 107, 302–316 (2025).Google Scholar Chen, X., Shi, C., He, M., Xiong, S. & Xia, X. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct. Target Ther. 8, 352 (2023).Google Scholar Chen, L. W. et al. The Epstein-Barr Virus Lytic Protein BMLF1 Induces Upregulation of GRP78 Expression through ATF6 Activation. Int. J. Mol. Sci. 22, https://doi.org/10.3390/ijms22084024 (2021).Yue, L. L. & Du, X. Thrombospondin 1 Promotes Endoplasmic Reticulum Stress and Apoptosis in HK-2 Cells by Upregulating ATF6-CHOP. Curr. Med Sci. 42, 341–347 (2022).Google Scholar Sankrityayan, H., Kale, A., Shelke, V. & Gaikwad, A. B. Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells. Arch. Physiol. Biochem 130, 411–419 (2024).Google Scholar Chen, Y. Y. et al. Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy. Biochim Biophys. Acta Mol. Basis Dis. 1865, 2563–2575 (2019).Google Scholar Zhu, L. R., Cui, W. & Liu, H. P. Molecular mechanisms of endoplasmic reticulum stress-mediated acute kidney injury in juvenile rats and the protective role of mesencephalic astrocyte-derived neurotrophic factor. J. Pharm. Pharm. 77, 609–620 (2025).Google Scholar Guo, S. et al. Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis. Biomolecules 14, https://doi.org/10.3390/biom14080919 (2024).Qian, X. et al. SMN haploinsufficiency promotes ischemia/ reperfusion-induced AKI-to-CKD transition by endoplasmic reticulum stress activation. Faseb J. 37, e23276 (2023).Google Scholar Li, L. et al. Tauroursodeoxycholic acid inhibits TGF-β1-induced renal fibrosis markers in cultured renal mesangial cells by regulating endoplasmic reticulum stress. Exp. Ther. Med. 23, 432 (2022).Google Scholar Zhao, H. et al. Poricoic acid A attenuates renal fibrosis by inhibiting endoplasmic reticulum stress-mediated apoptosis. Braz. J. Med Biol. Res. 57, e14249 (2024).Google Scholar Smith, T. M., Wang, X., Zhang, W., Kulyk, W. & Nazarali, A. J. Hoxa2 plays a direct role in murine palate development. Dev. Dyn. 238, 2364–2373 (2009).Google Scholar Bridoux, L., Deneyer, N., Bergiers, I. & Rezsohazy, R. Molecular Analysis of the HOXA2-Dependent Degradation of RCHY1. PLoS One 10, e0141347 (2015).Google Scholar Liu, Z. et al. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients. Cell Cycle 19, 1632–1640 (2020).Google Scholar Zong, X., Fu, J., Wang, Z. & Wang, Q. The Diagnostic and Prognostic Values of HOXA Gene Family in Kidney Clear Cell Renal Cell Carcinoma. J. Oncol. 2022, 1762637 (2022).Google Scholar Jiang, M. et al. LncRNA-LINC00472 suppresses the malignant progression of non-small cell lung cancer via modulation of the miRNA-1275/Homeobox A2 axis. Adv. Clin. Exp. Med 33, 283–297 (2024).Google Scholar Samarelli, A. V. et al. Expression of HOXB7 in the Lung of Patients with Idiopathic Pulmonary Fibrosis: A Proof-of-Concept Study. Biomedicines 12, https://doi.org/10.3390/biomedicines12061321 (2024).Zhang, N., Guo, F. & Song, Y. HOXC8/TGF-β1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling. Biochem Biophys. Res Commun. 662, 39–46 (2023).Google Scholar Peng, L. et al. HOXA13 exerts a beneficial effect in albumin-induced epithelial-mesenchymal transition via the glucocorticoid receptor signaling pathway in human renal tubular epithelial cells. Mol. Med Rep. 14, 271–276 (2016).Google Scholar Li, X. et al. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis. Cell Death Dis. 15, 398 (2024).Google Scholar Xiao, X. et al. Hypermethylation leads to the loss of HOXA5, resulting in JAG1 expression and NOTCH signaling contributing to kidney fibrosis. Kidney Int 106, 98–114 (2024).Google Scholar Zeybel, M. et al. DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease. Clin. Epigenetics 8, 48 (2016).Google Scholar Wu, H., Qiu, Z., Wang, L. & Li, W. Renal Fibrosis: SIRT1 Still of Value. Biomedicines 12, https://doi.org/10.3390/biomedicines12091942 (2024).Hu, H. et al. SIRT1 regulates endoplasmic reticulum stress-related organ damage. Acta Histochem 126, 152134 (2024).Google Scholar Kim, H. et al. Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin. Int. J. Mol. Sci. 18, https://doi.org/10.3390/ijms18020305 (2017).Chang, J. W. et al. Up-Regulation of SIRT1 Reduces Endoplasmic Reticulum Stress and Renal Fibrosis. Nephron 133, 116–128 (2016).Google Scholar Kim, H., Baek, C. H., Chang, J. W., Yang, W. S. & Lee, S. K. Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression. Clin. Exp. Nephrol. 24, 205–215 (2020).Google Scholar Zhou, W. et al. Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho. Acta Pharm. Sin. 43, 2609–2623 (2022).Google Scholar Chen, Z. et al. lncRNA HOTAIRM1 promotes osteogenesis of hDFSCs by epigenetically regulating HOXA2 via DNMT1 in vitro. J. Cell Physiol. 235, 8507–8519 (2020).Google Scholar Kim, H. et al. Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis. Am. J. Physiol. Ren. Physiol. 308, F226–236 (2015).Google Scholar Guo, R. et al. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism. Int J. Cardiol. 191, 36–45 (2015).Google Scholar Benedetti, R. et al. ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression. Autophagy 20, 1854–1867 (2024).Google Scholar Wu, D. et al. Unfolded protein response factor ATF6 augments T helper cell responses and promotes mixed granulocytic airway inflammation. Mucosal Immunol. 16, 499–512 (2023).Google Scholar Zhou, R. et al. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism. Cell Physiol. Biochem 51, 2397–2420 (2018).Google Scholar Wu, Q. et al. Polystyrene nanoplastics-induced lung apoptosis and ferroptosis via ROS-dependent endoplasmic reticulum stress. Sci. Total Environ. 912, 169260 (2024).Google Scholar Zhou, Y. et al. TGF-β1 induces ROS to activate ferroptosis via the ERK1/2-WISP1 pathway to promote the progression of renal tubular epithelial cell fibrosis. Cytotechnology 77, 61 (2025).Google Scholar Makhammajanov, Z. et al. Tubular toxicity of proteinuria and the progression of chronic kidney disease. Nephrol. Dial. Transpl. 39, 589–599 (2024).Google Scholar Tsai, L. T. et al. Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo. Antioxidants (Basel) 12, https://doi.org/10.3390/antiox12111931 (2023).Cao, Y. et al. Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway. Front Pharm. 15, 1503628 (2024).Google Scholar Tian, J. et al. SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS/TRPM2/Ca(2+) channel. Clin. Exp. Med 23, 3465–3478 (2023).Google Scholar Sun, H. J. et al. Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3. Redox Biol. 38, 101813 (2021).Google Scholar Yuan, Q. et al. MiR-185-5p ameliorates endoplasmic reticulum stress and renal fibrosis by downregulation of ATF6. Lab Invest 100, 1436–1446 (2020).Google Scholar Khan, I., Amin, M. A., Eklund, E. A. & Gartel, A. L. Regulation of HOX gene expression in AML. Blood Cancer J. 14, 42 (2024).Google Scholar Song, Y. P. et al. Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer. J. Immunol. Res 2022, 5740971 (2022).Google Scholar De Palma, F. D. E. et al. Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival. Cell Death Differ. 32, 730–744 (2025).Google Scholar Mohan, K. N. DNMT1: catalytic and non-catalytic roles in different biological processes. Epigenomics 14, 629–643 (2022).Google Scholar Chen, Q. Q. et al. Neuraminidase 1 promotes renal fibrosis development in male mice. Nat. Commun. 14, 1713 (2023).Google Scholar Adachi, E. et al. Progranulin deficiency attenuates tubulointerstitial injury in a mouse unilateral ureteral obstruction model. Exp. Anim. 73, 293–301 (2024).Google Scholar Rouschop, K. M. et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 15, 674–686 (2004).Google Scholar Badid, C. et al. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol. Dial. Transpl. 17, 1993–1998 (2002).Google Scholar Li, X. et al. MYCT1 attenuates renal fibrosis and tubular injury in diabetic kidney disease. iScience 26, 107609 (2023).Google Scholar Loos, B. et al. TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis. Cell Death Dis. 15, 925 (2024).Google Scholar Li, X. et al. YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway. Front Pharm. 14, 1069348 (2023).Google Scholar Yang, J. W. et al. Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis. J. Transl. Med. 21, 921 (2023).Google Scholar Neveu, W. A., Mills, S. T., Staitieh, B. S. & Sueblinvong, V. TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts. Am. J. Physiol. Cell Physiol. 309, C616–626 (2015).Google Scholar Li, P. et al. An improved cell nuclear isolation method. Biol. Methods Protoc. 10, bpaf007 (2025).Google Scholar Download referencesAcknowledgementsWe thank for the support from Department of Nephrology, Neurology and Anesthesiology of Fourth Affiliated Hospital of China Medical University, Department of Biological Therapy of First Affiliated Hospital of China Medical University and Department of Pathology of Shengjing Hospital of China Medical University. The study was supported by the National Natural Science Foundation of China (82402721), Liaoning Province Postdoctoral Science Fund (3110211225) and Science and Technology Project of Liaoning Province (2025080736-JH3/101).Author informationAuthor notesThese authors contributed equally: Xin Li, Tian-Kui Ma, Xiao-Xu Deng.Authors and AffiliationsNephrology Department, the Fourth Hospital of China Medical University, Shenyang, ChinaXin Li, Sang Hai, Fang Ma, Yun Zou, Qi Yang & Hong DingBiological Therapy Department, the First Hospital of China Medical University, Shenyang, ChinaTian-Kui MaPathology Department, Shengjing Hospital of China Medical University, Shenyang, ChinaXiao-Xu DengNeurology Department, the Fourth Hospital of China Medical University, Shenyang, ChinaHui LyuAnesthesiology Department, the Fourth Hospital of China Medical University, Shenyang, ChinaYu-Xi LiAuthorsXin LiView author publicationsSearch author on:PubMed Google ScholarTian-Kui MaView author publicationsSearch author on:PubMed Google ScholarXiao-Xu DengView author publicationsSearch author on:PubMed Google ScholarSang HaiView author publicationsSearch author on:PubMed Google ScholarFang MaView author publicationsSearch author on:PubMed Google ScholarYun ZouView author publicationsSearch author on:PubMed Google ScholarQi YangView author publicationsSearch author on:PubMed Google ScholarHui LyuView author publicationsSearch author on:PubMed Google ScholarYu-Xi LiView author publicationsSearch author on:PubMed Google ScholarHong DingView author publicationsSearch author on:PubMed Google ScholarContributionsAll authors approved final version of manuscript. X.L., T.M., X.D., H.L., Y.L. and H.D. conceived and designed research and performed experiments. S.H., F.M., Y.Z., Q.Y. X.D. and X.L. analyzed data. X.L., T.M., H.L. and Y.L. prepared figures and edited text. X.L., T.M., and X.D. drafted manuscript. H.L., Y.L., and H.D. edited and revised manuscript. H.L., Y.L., and H.D. given final approval of the version to be published.Corresponding authorsCorrespondence to Hui Lyu, Yu-Xi Li or Hong Ding.Ethics declarationsCompeting interestsThe authors declare no competing interests.Peer reviewPeer review informationCommunications Biology thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editors: Dr Toshiro Moroishi and Dr Ophelia Bu. [A peer review file is available].Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary informationTransparent Peer Review fileSupplementary informationDescription of Additional Supplementary FilesSupplementary Data 1reporting-summaryRights and permissionsOpen Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.Reprints and permissionsAbout this articleDownload PDF